Kura Oncology initiates coverage with overweight rating; target price $30
KURA•JPMorgan initiated coverage of Kura Oncology with an overweight rating and a $30 price target.
Related News
Kratos Defense & Security Solutions: Jefferies cuts target price to $68 from $80
KTOS•
XPeng September deliveries rise 5% to 41,256 vehicles
XPEV•
RBC cuts Agree Realty target price to $73 from $82
ADC•
Fresenius buys remaining 45% of mAbxience for up to EUR 750 million
FSNUY•
Jabil Inc.: JPMorgan raises target price to $430 from $425
JBL•